tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market
Advertisement

Hightide Therapeutics Inc (2511) Income Statement

Compare
0 Followers

Hightide Therapeutics Inc Income Statement

Last quarter (Q2 2025), Hightide Therapeutics Inc's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q2, Hightide Therapeutics Inc's net income was ¥-120.32K. See Hightide Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ -2.02M¥ -1.30M¥ -1.56M
Operating Expenses
¥ 444.75K¥ 454.37M¥ 229.56M¥ 128.33M
Depreciation and Amortization
¥ 537.00¥ 2.02M¥ 1.30M¥ 276.00K
EBITDA
¥ -444.22K¥ -1.04B¥ -229.56M¥ -131.80M
Operating Income
¥ -444.75K¥ -456.39M¥ -226.08M¥ -132.08M
Other Income/Expenses
¥ 63.23K¥ -581.45M¥ 35.88M¥ -88.97M
Pretax Income
¥ -381.52K¥ -1.04B¥ -190.21M¥ -221.05M
Net Income
¥ -381.79K¥ -1.04B¥ -190.24M¥ -221.15M
Per Share Metrics
Basic EPS
¥ -0.84¥ -4.00¥ -0.38¥ -0.42
Diluted EPS
¥ -0.84¥ -4.00¥ -0.38¥ -0.42
Weighted Average Shares Outstanding
452.08M 483.42M 514.77M 514.77M
Weighted Average Shares Outstanding (Diluted)
452.08M 483.42M 514.77M 514.77M
Currency in CNY

Hightide Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis